top of page

Our Team

World-class researchers pioneering the future of cardiac therapeutics

Lior Zangi, PhD

Founder and Principal Investigator

Associate Professor of Cardiology

Associate Professor of Genetics and Genomic Sciences

Cahn Soon-Shiong Professorship in Cardiovascular Research

Icahn School of Medicine at Mount Sinai

Dr. Lior Zangi is an experienced researcher in cardiac regeneration and modified mRNA therapeutics. His groundbreaking research focuses on methods for delivering modified mRNA (modRNA) to the heart to induce cardiac and cardiovascular regeneration and protection following ischemic injury.

​

His published work represents several world-firsts in the field: demonstrating modRNA delivery into cardiac and skeletal muscle, pioneering the use of modRNA to treat ischemic heart disease, and showing that modRNA technology can generate cardiac repair after heart attack and prevent heart failure formation in both small and large animals.

​

Dr. Zangi holds tenure at Mount Sinai and serves as the Chan Soon-Shiong Professor in Cardiovascular Research, leading efforts to translate cutting-edge modRNA science into life-changing therapies for patients with heart disease.

Magdalena Żak, PhD

Instructor of Medicine

Icahn School of Medicine at Mount Sinai

Matteo Ghiringhelli, PhD

Postdoctoral Fellow

Icahn School of Medicine at Mount Sinai

Matthew Adjmi, MSc

PhD Student

Icahn School of Medicine at Mount Sinai

Pioneering the future of cardiac therapy through cardiomyocyte-selective modRNA translation to transform hearts and lives.

2026 SeleRNA. All Rights Reserved. | Advancing Cardiac Therapeutics Through Innovative ModRNA Technology

bottom of page